Navigation Links
Europe develops new technologies to boost health of livestock

A range of new technologies including genetic modification (GM) and RNA Interference are being deployed to improve the health of farm animals in a series of European and global initiatives. The ground was laid for a European platform to develop new treatments that exploit these technologies at a recent workshop organised by the European Science Foundation (ESF).

The workshop highlighted the interlocking themes underlying the debate over livestock disease research, following a series of high profile epidemics and pandemics over the last two decades, including BSE, foot and mouth disease, bird flu, and PRRSV (Porcine Reproductive and Respiratory Syndrome Virus) in pigs, coupled with the public relations problems facing GM technologies.

It was clear that new technologies under the banner of GM have the potential to provide disease resistance with huge benefits for human health, animal welfare, and the agricultural sector, but only if public confidence can be restored. The ethical and societal dimension therefore featured strongly during the ESF workshop, according to convenor Bruce Whitelaw, Head of Developmental Biology at the Roslin Institute and Royal (Dick) School of Veterinary Studies in Scotland. There was a very thought provoking presentation by Kenneth Boyd (from Environmental Research Institute in UK) on what our conscience wants. This was one of the scene setting talks and was intended to make us consider up-front the ethical debate, said Whitelaw.

A major issue with GM was that it was deployed too soon with inefficient, inaccurate technology, and often for the wrong reasons, to benefit farmers and pharmaceutical companies rather than consumers. But the technical limitations are being overcome through new methods highlighted at the ESF workshop. There was a very exciting presentation by Chamsy Sarkis (Centre National de la Recherche Scientifique in France) indicating the amazing new technologies and methods for gene transfer. The take home message is that soon we will be able to engineer the animal genome efficiently and in a precise manner, said Whitelaw.

At the same time GM technologies are being redirected towards animal health and welfare, according to Whitelaw. The use of GM in farm species has been to-date focussed on high value products (e.g. animal bioreactors producing pharmaceuticals in milk). In the future much more effort will be applied to improve the health and welfare of animals through GM technology, with a second important topic being the generation of more appropriate animal models of human disease to enhance the development of better disease intervention strategies.

There has already been some success employing GM techniques to engineer disease resistance in animals. It is now possible to produce cattle lacking the gene that makes the prion protein responsible for BSE. Calves produced this way appear to be completely healthy, suggesting that the prion protein is not necessary, or that it has back up proteins that perform its functions. Either way, there is a real prospect of eliminating BSE from cattle livestock.

In the case of viral disease, other techniques apart from GM may be appropriate. The huge potential of RNA Interference was discussed at the conference, whereby the ability of viruses to produce the proteins they need for replication from the genetic information encoded in their RNA is blocked. This could help prevent pigs from contracting the deadly PRRSV, or chickens from getting bird flu.

But much more research is needed, and the ESF workshop helped bring together researchers with the relevant expertise in Europe. The workshop identified Europes leading position in livestock disease research, spearheaded by the Scottish Network of Excellence Development of Novel Technologies to Fight Viral Diseases in Farm Animals, which is a model for a possible Europe-wide consortium.

The ESF Exploratory Workshop on Genetic Models of Disease Resistance in Livestock was held in Edinburgh, UK in October 2007.

Each year, ESF supports approximately 50 Exploratory Workshops across all scientific domains. These small, interactive group sessions are aimed at opening up new directions in research to explore new fields with a potential impact on developments in science.


Contact: Dr. Bruce Whitelaw
European Science Foundation

Related biology news :

1. European membrane expertise to focus on new treatments for human diseases
2. ESFs European ice core project EPICA receives prestigious Descartes Prize
3. Europes most common genetic disease is a liver disorder
4. First European Lung Cancer Conference
5. Final preparations for first human-rated spacecraft to be lauched from Europes Spaceport
6. EMBO Installation Grants help 9 scientists set up in Europe
7. European Union forests expanding, absorbing carbon at surprisingly high rate: study
8. IdentiPHI Opens Paris Office to Boost European Sales and Support
9. Great potential to improve collection, recycling of Europes electronic waste, says UN report
10. Hot spots the key to controlling European carp in Australia
11. Fossilized cashew nuts reveal Europe was important route between Africa and South America
Post Your Comments:
(Date:11/16/2015)... , Nov 16, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced expansion of its TDDI ... touch controller and display driver integration (TDDI) ... smartphones. These new TDDI products add to the ... resolution), TD4302 (WQHD resolution), and TD4322 (FHD resolution) ...
(Date:11/12/2015)... LONDON , Nov. 11, 2015   ... and reliable analytical tools has been paving the ... and qualitative determination of discrete analytes in clinical, ... sensors are being predominantly used in medical applications, ... and environmental sectors due to continuous emphasis on ...
(Date:11/10/2015)... About signature verification Signature ... identify and verify the identity of an individual ... secure and accurate method of authentication and is ... because each individual,s signature is highly unique. Signature ... signature of an individual is compared and matched ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... Conference in New York on Wednesday, December ... Helen Torley , president and CEO, will provide a corporate overview. ... New York at 1:00 p.m. ET/10:00 a.m. PT . ... investor relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... Global, Inc., a worldwide provider of clinical research services headquartered in ... company has set a new quarterly earnings record in Q3 of ... for Q3 of 2014 to Q3 of 2015.   ... with the establishment of an Asia-Pacific office ... Kingdom and Mexico , with the ...
(Date:11/24/2015)... , November 24, 2015 ... recent market research report released by Transparency Market Research, ... expand at a CAGR of 17.5% during the period ... Testing Market - Global Industry Analysis, Size, Volume, Share, ... global non-invasive prenatal testing market to reach a valuation ...
(Date:11/24/2015)... ... November 24, 2015 , ... InSphero AG, the leading supplier of easy-to-use ... promoted Melanie Aregger to serve as Chief Operating Officer. , Having joined ... management team and was promoted to Head of InSphero Diagnostics in 2014. ...
Breaking Biology Technology: